Investing
Top 10 Analyst Upgrades and Downgrades (BIIB, CMA, ENER, ESLR, FSLR, MAT, HK, TRV, YUM, ZRAN)
Published:
Last Updated:
These are this Tuesday morning’s top analyst upgrades, downgrades, and initiations seen in early Wall Street research notes:
Biogen Idec (NASDAQ: BIIB) Started as Buy at Soleil.
Comerica (NYSE: CMA) Cut to Market Perform at BMO Capital.
Energy Conversion Devices (NASDAQ: ENER) Cut to Underweight at JPMorgan.
Evergreen Solar (NASDAQ: ESLR) Cut to Neutral at JPMorgan.
First Solar Inc. (NASDAQ: FSLR) Cut to Underweight at JPMorgan.
Mattel Inc. (NYSE: MAT) Raised to Buy at Citi.
Petrohawk Energy (NYSE: HK) Raised to Outperform at Wells Fargo.
The Travelers Companies, Inc. (NYSE: TRV) Started as Buy at Citigroup.
YUM! Brands (NYSE: YUM) Raised to Buy at UBS.
Zoran Corporation (NASDAQ: ZRAN) Cut to Hold at Collins Stewart.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
